Nobuhiro Oikawa

1.5k total citations · 1 hit paper
21 papers, 1.2k citations indexed

About

Nobuhiro Oikawa is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Nobuhiro Oikawa has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Nobuhiro Oikawa's work include Cancer therapeutics and mechanisms (6 papers), Insect and Pesticide Research (5 papers) and Insect Pest Control Strategies (3 papers). Nobuhiro Oikawa is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Insect and Pesticide Research (5 papers) and Insect Pest Control Strategies (3 papers). Nobuhiro Oikawa collaborates with scholars based in Japan, United States and Germany. Nobuhiro Oikawa's co-authors include Hiroshi Sakamoto, Toshiyuki Tsukaguchi, Takuo Tsukuda, Takamitsu Kobayashi, Nobuya Ishii, Yuko Aoki, Takaaki A. Fukami, Tatsushi Kodama, Yoshiaki Nakagawa and Toshio Fujita and has published in prestigious journals such as Cancer Cell, Journal of Medicinal Chemistry and Cancer Letters.

In The Last Decade

Nobuhiro Oikawa

21 papers receiving 1.1k citations

Hit Papers

CH5424802, a Selective ALK Inhibitor Capable of Blocking ... 2011 2026 2016 2021 2011 100 200 300 400 500

Peers

Nobuhiro Oikawa
Veeraswamy Manne United States
Chong Hak Chae South Korea
E. A. Partridge United Kingdom
Sang Min Lim South Korea
Jian Song China
Gregory R. Ott United States
Veeraswamy Manne United States
Nobuhiro Oikawa
Citations per year, relative to Nobuhiro Oikawa Nobuhiro Oikawa (= 1×) peers Veeraswamy Manne

Countries citing papers authored by Nobuhiro Oikawa

Since Specialization
Citations

This map shows the geographic impact of Nobuhiro Oikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhiro Oikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhiro Oikawa more than expected).

Fields of papers citing papers by Nobuhiro Oikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuhiro Oikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhiro Oikawa. The network helps show where Nobuhiro Oikawa may publish in the future.

Co-authorship network of co-authors of Nobuhiro Oikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuhiro Oikawa. A scholar is included among the top collaborators of Nobuhiro Oikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuhiro Oikawa. Nobuhiro Oikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ito, Toshiya, Masaki Tomizawa, Masayuki Matsushita, et al.. (2022). Discovery of CH7057288 as an Orally Bioavailable, Selective, and Potent pan-TRK Inhibitor. Journal of Medicinal Chemistry. 65(18). 12427–12444. 4 indexed citations
2.
Tanaka, Hiroshi, Hitoshi Sase, Toshiyuki Tsukaguchi, et al.. (2018). Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer. Molecular Cancer Therapeutics. 17(12). 2519–2529. 17 indexed citations
3.
Aida, Satoshi, et al.. (2017). MITF suppression improves the sensitivity of melanoma cells to a BRAF inhibitor. Cancer Letters. 409. 116–124. 26 indexed citations
4.
Sakamoto, Hiroshi, Toshiyuki Tsukaguchi, Tatsushi Kodama, et al.. (2011). CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant. Cancer Cell. 19(5). 679–690. 508 indexed citations breakdown →
5.
Ono, Yoshiyuki, Takashi Emura, Kohsuke Asoh, et al.. (2011). Discovery of novel tetracyclic compounds as anaplastic lymphoma kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(12). 3788–3793. 27 indexed citations
6.
Asoh, Kohsuke, Noriyuki Furuichi, Toshiya Ito, et al.. (2011). Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802). Bioorganic & Medicinal Chemistry. 20(3). 1271–1280. 134 indexed citations
7.
Kobayashi, Takamitsu, Kohsuke Asoh, Noriyuki Furuichi, et al.. (2011). 9-Substituted 6,6-Dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles as Highly Selective and Potent Anaplastic Lymphoma Kinase Inhibitors. Journal of Medicinal Chemistry. 54(18). 6286–6294. 61 indexed citations
8.
Takahashi, Hidenori, Yasuhiro Tamaki, Nobuya Ishii, et al.. (2008). Identification of a Novel Vascular Endothelial Growth Factor Receptor 2 Inhibitor and Its Effect for Choroidal NeovascularizationIn Vivo. Current Eye Research. 33(11-12). 1002–1010. 20 indexed citations
9.
Kohchi, Yasunori, Kazuo Hattori, Nobuhiro Oikawa, et al.. (2007). Design and synthesis of novel prodrugs of 2′-deoxy-2′-methylidenecytidine activated by membrane dipeptidase overexpressed in tumor tissues. Bioorganic & Medicinal Chemistry Letters. 17(8). 2241–2245. 5 indexed citations
10.
Wheelock, Craig E., Yoshiaki Nakagawa, Toshiyuki Harada, et al.. (2005). High-throughput screening of ecdysone agonists using a reporter gene assay followed by 3-D QSAR analysis of the molting hormonal activity. Bioorganic & Medicinal Chemistry. 14(4). 1143–1159. 42 indexed citations
11.
Hattori, Kazuo, Yasunori Kohchi, Nobuhiro Oikawa, et al.. (2003). Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine. Bioorganic & Medicinal Chemistry Letters. 13(5). 867–872. 22 indexed citations
12.
Ohwada, Jun, Masao Tsukazaki, Tadakatsu Hayase, et al.. (2003). Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole. Bioorganic & Medicinal Chemistry Letters. 13(2). 191–196. 63 indexed citations
14.
Nakagawa, Yoshiaki, Keiichiro Nishimura, Nobuhiro Oikawa, & Norio Kurihara. (1995). Activity of ecdysone analogs in enhancing N-acetylglucosamine incorporation into the cultured integument of Chilo suppressalis. Steroids. 60(5). 401–405. 25 indexed citations
16.
Oikawa, Nobuhiro, et al.. (1994). Quantitative Structure-Activity Studies of Insect Growth Regulators. Pesticide Biochemistry and Physiology. 48(2). 135–144. 45 indexed citations
17.
Oikawa, Nobuhiro, Yoshiaki Nakagawa, Keiichiro Nishimura, Tamio Ueno, & Toshio Fujita. (1994). Quantitative structure‐activity analysis of larvicidal 1‐(substituted benzoyl)‐2‐benzoyl‐1‐tert‐butylhydrazines against Chilo suppressalis. Pesticide Science. 41(2). 139–147. 40 indexed citations
18.
Oikawa, Nobuhiro, Yoshiaki Nakagawa, Yoshihiro Soya, et al.. (1993). Enhancement of N-Acetylglucosamine Incorporation into the Cultured Integument of Chilo suppressalis by Molting Hormone and Dibenzoylhydrazine Insecticides. Pesticide Biochemistry and Physiology. 47(3). 165–170. 32 indexed citations
19.
Nakagawa, Yoshiaki, et al.. (1992). Analysis and prediction of hydrophobicity parameters of substituted acetanilides, benzamides and related aromatic compounds. Environmental Toxicology and Chemistry. 11(7). 901–916. 36 indexed citations
20.
Nakagawa, Yoshiaki, et al.. (1991). Quantitative structure-activity relationships of benzoylphenylurea larvicides. Pesticide Biochemistry and Physiology. 40(1). 12–26. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026